Alterity Therapeutics Limited (ASX:ATH)

CTI BioPharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	129	21	17	31	58	18
Market Cap Growth	116.97%	22.84%	-45.41%	-46.38%	230.89%	-29.36%
Enterprise Value	124	9	-8	-6	23	5
Last Close Price	0.01	0.00	0.01	0.01	0.03	0.02
PS Ratio	34.61	5.22	4.36	6.11	13.45	-
PB Ratio	16.56	1.52	0.75	0.88	1.92	2.47
P/TBV Ratio	16.56	1.52	0.75	0.88	1.92	2.47
EV/Sales Ratio	33.42	2.22	-	-	5.37	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	0.01
Asset Turnover	0.23	0.17	0.11	0.14	0.20	-
Quick Ratio	3.76	3.10	5.58	6.79	10.56	3.41
Current Ratio	3.84	3.54	6.17	7.07	10.92	3.62
Return on Equity (ROE)	-155.77%	-104.47%	-47.38%	-38.97%	-81.39%	-113.53%
Return on Assets (ROA)	-78.37%	-52.66%	-26.64%	-25.85%	-43.62%	-58.39%
Return on Capital (ROIC)	-99.57%	-66.27%	-31.21%	-29.30%	-50.30%	-73.35%
Earnings Yield	-15.35%	-91.15%	-80.84%	-41.06%	-26.24%	-76.31%
FCF Yield	-	-60.11%	-117.35%	-39.72%	-29.72%	-53.57%
Buyback Yield / Dilution	-104.33%	-50.29%	-0.91%	-41.79%	-89.62%	-45.32%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.